XML 41 R30.htm IDEA: XBRL DOCUMENT v3.24.3
Nature of Operations and Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
May 07, 2024
Feb. 15, 2022
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Product Information [Line Items]              
Proceeds from issuance of common stock   $ 21,711,000          
Reverse stock split, description one-for-twelve            
FDIC insured amount     $ 250,000   $ 250,000    
Cash balance, amount     10,295,159   10,295,159   $ 12,508,251
FDIC uninsured amount     10,045,000   10,045,000    
Allowance for doubtful accounts receivable         85,000   125,000
Provision for doubtful accounts         $ (40,094) $ (2,056)  
Potentially dilutive equity instruments that are convertible into common stock         643,906 666,069  
Contract assets     224,414   $ 224,414   224,414
Allowance for doubtful accounts     1,436   1,436   1,436
Contract with customer liability current     468,963   468,963   499,800
Revenue recognized     0 $ 12,461 116,610 $ 3,911,083  
Revenue remaining performance obligation     352,000 $ 548,000 $ 352,000 $ 548,000  
Product warranty description         The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue.    
Accrued warranty reserve amount     $ 53,527   $ 53,527   $ 191,338
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer One [Member]              
Product Information [Line Items]              
Concentration risk percentage     43.00% 29.00% 54.00% 38.00%  
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Two [Member]              
Product Information [Line Items]              
Concentration risk percentage     39.00% 19.00%   20.00%  
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Three [Member]              
Product Information [Line Items]              
Concentration risk percentage       16.00%   12.00%  
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Four [Member]              
Product Information [Line Items]              
Concentration risk percentage       12.00%      
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer One [Member]              
Product Information [Line Items]              
Concentration risk percentage         55.00%   59.00%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Two [Member]              
Product Information [Line Items]              
Concentration risk percentage         34.00%   29.00%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Three [Member]              
Product Information [Line Items]              
Concentration risk percentage         11.00%   12.00%
Maximum [Member]              
Product Information [Line Items]              
Revenue remaining performance obligation     $ 196,000   $ 196,000    
Director and Staff [Member]              
Product Information [Line Items]              
Potentially dilutive equity instruments that are convertible into common stock         26,121 30,755  
Series B Preferred Stock [Member]              
Product Information [Line Items]              
Potentially dilutive equity instruments that are convertible into common stock         617,785 635,314